• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机器学习的病理组学模型预测透明细胞肾细胞癌的预后

Machine Learning-Based Pathomics Model to Predict the Prognosis in Clear Cell Renal Cell Carcinoma.

作者信息

Li Xiangyun, Yang Xiaoqun, Yang Xianwei, Xie Xin, Rui Wenbin, He Hongchao

机构信息

Department of Pathology, Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Department of Urology, Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

出版信息

Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241307686. doi: 10.1177/15330338241307686.

DOI:10.1177/15330338241307686
PMID:39703069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11662324/
Abstract

Clear cell renal cell carcinoma (ccRCC) is a highly lethal urinary malignancy with poor overall survival (OS) rates. Integrating computer vision and machine learning in pathomics analysis offers potential for enhancing classification, prognosis, and treatment strategies for ccRCC. This study aims to create a pathomics model to predict OS in ccRCC patients. In this study, data from ccRCC patients in the TCGA database were used as a training set, with clinical data serving as a validation set. Pathological features were extracted from H&E-stained slides using PyRadiomics, and a pathomics model was constructed using the non-negative matrix factorization (NMF) algorithm. The model's predictive performance was assessed through Kaplan-Meier (KM) survival curves and Cox regression analysis. Additionally, differential gene expression, gene ontology (GO) enrichment analysis, immune infiltration, and mutational analysis were conducted to investigate the underlying biological mechanisms. A total of 368 pathomics features were extracted from H&E-stained slides of ccRCC patients, and a pathomics model comprising two subtypes (Cluster 1 and Cluster 2) was successfully constructed using the NMF algorithm. KM survival curves and Cox regression analysis revealed that Cluster 2 was associated with worse OS. A total of 76 differential genes were identified between the two subtypes, primarily involving extracellular matrix organization and structure. Immune-related genes, including CTLA4, CD80, and TIGIT, were highly expressed in Cluster 2, while the VHL and PBRM1 genes, along with mutations in the PI3K-Akt, HIF-1, and MAPK signaling pathways, exhibited mutation rates exceeding 40% in both subtypes. The machine learning-based pathomics model effectively predicts the OS of ccRCC patients and differentiates between subtypes. The critical roles of the immune-related gene CTLA4 and the PI3K-Akt, HIF-1, and MAPK signaling pathways offer new insights for further research on the molecular mechanisms, diagnosis, and treatment strategies for ccRCC.

摘要

透明细胞肾细胞癌(ccRCC)是一种具有高致死率的泌尿系统恶性肿瘤,总体生存率(OS)较低。将计算机视觉和机器学习整合到病理组学分析中,为改善ccRCC的分类、预后和治疗策略提供了潜力。本研究旨在创建一个病理组学模型来预测ccRCC患者的OS。在本研究中,来自TCGA数据库中ccRCC患者的数据用作训练集,临床数据用作验证集。使用PyRadiomics从苏木精-伊红(H&E)染色的切片中提取病理特征,并使用非负矩阵分解(NMF)算法构建病理组学模型。通过Kaplan-Meier(KM)生存曲线和Cox回归分析评估该模型的预测性能。此外,还进行了差异基因表达、基因本体(GO)富集分析、免疫浸润和突变分析,以探究潜在的生物学机制。从ccRCC患者的H&E染色切片中总共提取了368个病理组学特征,并使用NMF算法成功构建了一个包含两个亚型(Cluster 1和Cluster 2)的病理组学模型。KM生存曲线和Cox回归分析显示,Cluster 2与较差的OS相关。在两个亚型之间总共鉴定出76个差异基因,主要涉及细胞外基质组织和结构。包括CTLA4、CD80和TIGIT在内的免疫相关基因在Cluster 2中高表达,而VHL和PBRM1基因以及PI3K-Akt、HIF-1和MAPK信号通路中的突变在两个亚型中的突变率均超过40%。基于机器学习的病理组学模型能够有效地预测ccRCC患者的OS并区分亚型。免疫相关基因CTLA4以及PI3K-Akt、HIF-1和MAPK信号通路的关键作用,为进一步研究ccRCC的分子机制、诊断和治疗策略提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/1dd01ea3160d/10.1177_15330338241307686-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/5ceeafdac4e8/10.1177_15330338241307686-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/040b19fb389e/10.1177_15330338241307686-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/4b2c6a357434/10.1177_15330338241307686-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/e45d4896bc1d/10.1177_15330338241307686-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/2f7a129b683d/10.1177_15330338241307686-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/351cc425c4de/10.1177_15330338241307686-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/2d35d09b44ae/10.1177_15330338241307686-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/1dd01ea3160d/10.1177_15330338241307686-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/5ceeafdac4e8/10.1177_15330338241307686-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/040b19fb389e/10.1177_15330338241307686-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/4b2c6a357434/10.1177_15330338241307686-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/e45d4896bc1d/10.1177_15330338241307686-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/2f7a129b683d/10.1177_15330338241307686-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/351cc425c4de/10.1177_15330338241307686-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/2d35d09b44ae/10.1177_15330338241307686-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c303/11662324/1dd01ea3160d/10.1177_15330338241307686-fig8.jpg

相似文献

1
Machine Learning-Based Pathomics Model to Predict the Prognosis in Clear Cell Renal Cell Carcinoma.基于机器学习的病理组学模型预测透明细胞肾细胞癌的预后
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241307686. doi: 10.1177/15330338241307686.
2
Computed tomography-based radiomics predicts prognostic and treatment-related levels of immune infiltration in the immune microenvironment of clear cell renal cell carcinoma.基于计算机断层扫描的放射组学可预测透明细胞肾细胞癌免疫微环境中免疫浸润的预后及治疗相关水平。
BMC Med Imaging. 2025 Jul 1;25(1):213. doi: 10.1186/s12880-025-01749-3.
3
Kinesin-related genes stratified the prognosis and immune responses of clear cell renal cell carcinoma.驱动蛋白相关基因可对透明细胞肾细胞癌的预后和免疫反应进行分层。
Eur J Med Res. 2025 Jul 14;30(1):621. doi: 10.1186/s40001-025-02880-1.
4
Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.鉴定和验证与透明细胞肾细胞癌预后相关的新型凋亡相关基因特征。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11661-11678. doi: 10.1007/s00432-023-05012-6. Epub 2023 Jul 5.
5
Multi-omics analysis reveals the role of ribosome biogenesis in malignant clear cell renal cell carcinoma and the development of a machine learning-based prognostic model.多组学分析揭示核糖体生物合成在恶性透明细胞肾细胞癌中的作用以及基于机器学习的预后模型的开发。
Front Immunol. 2025 Jun 26;16:1602898. doi: 10.3389/fimmu.2025.1602898. eCollection 2025.
6
Identification of CXCR4 as a potential preventive gene in clear cell renal cell carcinoma from machine learning and immune analysis.通过机器学习和免疫分析确定CXCR4作为透明细胞肾细胞癌潜在预防基因
Sci Rep. 2025 Jul 1;15(1):21321. doi: 10.1038/s41598-025-08199-5.
7
Bioinformatics identification and validation of m6A/m1A/m5C/m7G/ac4 C-modified genes in oral squamous cell carcinoma.口腔鳞状细胞癌中m6A/m1A/m5C/m7G/ac4C修饰基因的生物信息学鉴定与验证
BMC Cancer. 2025 Jul 1;25(1):1055. doi: 10.1186/s12885-025-14216-7.
8
Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer.整合蛋白质组学和转录组学分析揭示雌激素受体阳性/孕激素受体阳性与雌激素受体阳性/孕激素受体阴性乳腺癌之间的关键调控基因。
BMC Cancer. 2025 Jul 1;25(1):1048. doi: 10.1186/s12885-025-14451-y.
9
Construction and validation of a lipid metabolism-related genes prognostic signature for skin cutaneous melanoma.皮肤黑色素瘤脂质代谢相关基因预后特征的构建与验证
Biochem Biophys Res Commun. 2025 May 29;775:152115. doi: 10.1016/j.bbrc.2025.152115.
10
NME4: A novel metabolic-associated biomarker for prognosis prediction and immunotherapy response evaluation in clear cell renal cell carcinoma.NME4:一种用于透明细胞肾细胞癌预后预测和免疫治疗反应评估的新型代谢相关生物标志物。
Mol Immunol. 2025 Aug;184:149-163. doi: 10.1016/j.molimm.2025.06.011. Epub 2025 Jul 1.

本文引用的文献

1
Resveratrol liposomes reverse sorafenib resistance in renal cell carcinoma models by modulating PI3K-AKT-mTOR and VHL-HIF signaling pathways.白藜芦醇脂质体通过调节PI3K-AKT-mTOR和VHL-HIF信号通路逆转肾细胞癌模型中的索拉非尼耐药性。
Int J Pharm X. 2024 Aug 26;8:100280. doi: 10.1016/j.ijpx.2024.100280. eCollection 2024 Dec.
2
Integration of proteomics and transcriptomics to construct a prognostic signature of renal clear cell carcinoma.蛋白质组学和转录组学的整合构建肾透明细胞癌的预后标志物。
Int J Med Sci. 2024 Aug 19;21(11):2215-2232. doi: 10.7150/ijms.99992. eCollection 2024.
3
Predicting CTLA4 expression and prognosis in clear cell renal cell carcinoma using a pathomics signature of histopathological images and machine learning.
利用组织病理学图像的病理组学特征和机器学习预测透明细胞肾细胞癌中的CTLA4表达及预后
Heliyon. 2024 Jul 18;10(15):e34877. doi: 10.1016/j.heliyon.2024.e34877. eCollection 2024 Aug 15.
4
Prognostic significance of TNFRSF4 expression and development of a pathomics model to predict expression in hepatocellular carcinoma.TNFRSF4表达的预后意义及预测肝细胞癌中表达的病理组学模型的建立
Heliyon. 2024 May 24;10(11):e31882. doi: 10.1016/j.heliyon.2024.e31882. eCollection 2024 Jun 15.
5
Development of a prognostic model based on different disulfidptosis related genes typing for kidney renal clear cell carcinoma.基于不同二硫键连接性坏死相关基因分型的肾透明细胞癌预后模型的开发
Front Pharmacol. 2024 Mar 13;15:1343819. doi: 10.3389/fphar.2024.1343819. eCollection 2024.
6
An Integrated Machine Learning Framework Identifies Prognostic Gene Pair Biomarkers Associated with Programmed Cell Death Modalities in Clear Cell Renal Cell Carcinoma.一种集成机器学习框架鉴定与透明细胞肾细胞癌程序性细胞死亡方式相关的预后基因对生物标志物。
Front Biosci (Landmark Ed). 2024 Mar 21;29(3):121. doi: 10.31083/j.fbl2903121.
7
Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing.通过单细胞和批量 RNA 测序的综合分析,确定和验证基于巨噬细胞标记基因的新型标志物,用于预测肾透明细胞癌的预后和药物反应。
Aging (Albany NY). 2024 Mar 20;16(6):5676-5702. doi: 10.18632/aging.205671.
8
The oncogene MYBL2 promotes the malignant phenotype and suppresses apoptosis through hedgehog signaling pathway in clear cell renal cell carcinoma.致癌基因MYBL2通过刺猬信号通路促进透明细胞肾细胞癌的恶性表型并抑制细胞凋亡。
Heliyon. 2024 Mar 11;10(6):e27772. doi: 10.1016/j.heliyon.2024.e27772. eCollection 2024 Mar 30.
9
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.揭示 CXCR2 作为肾细胞癌有希望的治疗靶点:通过 RCT001 抑制探索免疫治疗范式转变。
J Exp Clin Cancer Res. 2024 Mar 19;43(1):86. doi: 10.1186/s13046-024-02984-2.
10
Integrative analysis and risk model construction for super‑enhancer‑related immune genes in clear cell renal cell carcinoma.透明细胞肾细胞癌中超级增强子相关免疫基因的综合分析与风险模型构建
Oncol Lett. 2024 Mar 1;27(5):190. doi: 10.3892/ol.2024.14323. eCollection 2024 May.